Quick Answer
GLP-1 coverage for diabetes (Ozempic, Mounjaro) is broadly available across all states under commercial plans when HbA1c ≥7.0% and step therapy is satisfied. Weight-loss GLP-1s (Wegovy, Zepbound) are a different story: Medicare currently does not cover them for weight loss alone (statutory exclusion under Social Security Act §1860D-2(e)(2)(A)), and most state Medicaid programs follow. Commercial coverage varies by employer-plan formulary. Always verify whether your specific employer plan includes a weight-loss benefit rider before requesting Wegovy or Zepbound.
Last updated: 2026-05-26 · Source: AppealArmor · About the authors
GLP-1 Insurance Coverage by State (2024)
Ready to fight your denial? Generate your appeal letter in 5 minutes →
State Mandate Power
If your state has an obesity or diabetes medication coverage mandate, citing it directly in your appeal materially improves the odds of approval. Insurers tend to respond more readily to appeals that quote the specific statute or regulatory provision they are required to follow.
Critical: State mandates apply to "fully-insured" plans (state exchange, small employers) but NOT self-funded employer plans (exempt under ERISA).
States with GLP-1/Obesity Coverage Mandates
🟢 California - Strongest Obesity Drug Mandate
Law: SB 137 (Health and Safety Code Section 1367.008 / Insurance Code Section 10112.28)
What's Covered:
- FDA-approved obesity treatments including Wegovy, Zepbound (and off-label Ozempic, Mounjaro if BMI qualifies)
- Required for BMI ≥30 OR BMI ≥27 with weight-related comorbidity (diabetes, hypertension, dyslipidemia, sleep apnea)
Step Therapy Limitations:
- Plans CAN require prior authorization
- Plans CAN require ONE documented weight loss program failure (diet/exercise, behavioral counseling)
- Plans CANNOT require more than ONE prior authorization or multiple medication failures
Applies To:
- Fully-insured commercial health plans (Covered California exchange, small group employers)
- Does NOT apply to: Self-funded employer plans, Medi-Cal (Medicaid), Medicare
How to Use in Appeal:
"Under California Health and Safety Code Section 1367.008, my insurance plan is required to cover FDA-approved obesity treatments for individuals with BMI ≥30 or BMI ≥27 with comorbidity. I qualify with BMI [XX.X] and [comorbidity]. Denial violates California law. I am prepared to file a complaint with the California Department of Managed Health Care if coverage is not approved."
File Complaint: California DMHC: 888-466-2219 or dmhc.ca.gov
🟢 Illinois - Comprehensive Anti-Obesity Medication Access Act
Law: PA 103-0595 (effective January 1, 2024)
What's Covered:
- FDA-approved anti-obesity medications including GLP-1 drugs (Wegovy, Zepbound, Ozempic, Mounjaro)
- Required coverage for BMI ≥30 OR BMI ≥27 with obesity-related comorbidity
Step Therapy Limitations:
- Plans CANNOT require step therapy (fail first policies) for FDA-approved obesity medications
- Plans CAN require documentation of obesity-related health condition
- Plans CAN require evidence of lifestyle intervention attempts
Applies To:
- State-regulated health insurance plans (including ACA marketplace plans)
- Does NOT apply to: Self-funded employer plans, Medicaid, Medicare
How to Use in Appeal:
"Under Illinois PA 103-0595 (effective January 1, 2024), my insurance plan is prohibited from imposing step therapy requirements for FDA-approved obesity medications. My BMI is [XX.X] with [comorbidity], meeting coverage criteria. This denial violates Illinois law."
File Complaint: Illinois Department of Insurance: 877-527-9431 or insurance.illinois.gov
🟢 New York - Diabetes Medication Coverage Mandate
Law: NY Insurance Law Section 3216 (diabetes coverage mandate)
What's Covered:
- Comprehensive diabetes care including diabetes medications and equipment
- GLP-1 drugs (Ozempic, Mounjaro) for Type 2 Diabetes covered under diabetes mandate
- Wegovy/Zepbound for obesity: Limited mandate, varies by plan
Step Therapy Limitations:
- Plans cannot impose excessive step therapy barriers for diabetes treatment
- If A1C >8% or diabetic complications present, expedited coverage required
- Medical necessity determinations must consider individual patient circumstances
Applies To:
- Fully-insured commercial plans, NY State of Health (ACA marketplace)
- Does NOT apply to: Self-funded plans, Medicaid, Medicare
How to Use in Appeal:
"Under New York Insurance Law Section 3216, my insurance must provide comprehensive diabetes medication coverage. My A1C is [X.X]% with [complications], and I have failed prior therapies [metformin, sulfonylureas]. Denying GLP-1 therapy violates NY diabetes coverage requirements."
File Complaint: NY Department of Financial Services: 800-342-3736 or dfs.ny.gov
🟢 Massachusetts - Diabetes Care Mandate
Law: Massachusetts General Laws Chapter 176O, Section 8
What's Covered:
- Comprehensive diabetes care services and equipment
- Diabetes medications including GLP-1 drugs prescribed by physician
- Obesity treatment: No specific mandate, varies by plan
Step Therapy Limitations:
- Plans must cover medically necessary diabetes treatments
- Cannot deny coverage if prescribed by qualified healthcare provider for diabetes management
Applies To:
- State-regulated health insurance plans
- Does NOT apply to: Self-funded plans, MassHealth (Medicaid), Medicare
How to Use in Appeal:
"Under Massachusetts General Laws Chapter 176O, Section 8, my insurance must cover medically necessary diabetes care. My physician has determined GLP-1 therapy is medically necessary based on [A1C X.X%, prior failures, complications]. Denial violates MA diabetes coverage law."
File Complaint: MA Division of Insurance: 877-563-4467 or mass.gov/doi
States with Pending or Limited Mandates
🟡 States with Diabetes Coverage Requirements (May Help GLP-1 Appeals)
Connecticut: Comprehensive diabetes coverage law. Cite for Ozempic/Mounjaro denials.
Maryland: Diabetes care mandate including medications. Strong for diabetes-related GLP-1 appeals.
Rhode Island: Diabetes medication coverage required. Cite in appeals for Type 2 Diabetes treatment.
Vermont: Diabetes supplies and medications mandate. Applies to diabetes-approved GLP-1 drugs.
Washington: Comprehensive diabetes coverage. Some plans required to cover GLP-1 drugs.
New Jersey: Diabetes care mandate. Cite for Ozempic/Mounjaro appeals with diabetes indication.
🔴 States WITHOUT Specific GLP-1 or Obesity Mandates
Most states (44+) have NO specific obesity medication coverage requirements. In these states:
- Insurance companies can exclude weight loss drugs entirely
- No legal requirement to cover Wegovy, Zepbound, or off-label Ozempic/Mounjaro for weight loss
- Appeals must focus on medical necessity, prior failures, and clinical evidence rather than legal mandates
Strategy for non-mandate states:
- Emphasize prediabetes if present (switch from weight loss to diabetes prevention indication)
- Document obesity-related comorbidities making treatment medically necessary
- Use doctor medical necessity letter emphasizing patient-specific urgency
- Request peer-to-peer review with insurance medical director
How to Check Your Plan Type (Fully-Insured vs Self-Funded)
State Mandates Apply to Fully-Insured Plans ONLY
Fully-Insured Plans (Subject to State Mandates):
- Individual/family plans purchased through state ACA marketplace (Healthcare.gov or state exchange)
- Small group employer plans (typically <50 employees)
- Some mid-size employer plans regulated by state
Self-Funded Plans (EXEMPT from State Mandates - ERISA):
- Large employer plans (typically 100+ employees)
- Many mid-size employer plans (51-100 employees)
- Union/Taft-Hartley plans
- Federal employee plans (FEHB)
How to Check:
- Look at your insurance ID card:
- Says "Administered by [BCBS/Aetna/UHC]" but employer name on card → Likely self-funded
- Says just "Blue Cross" or "Aetna" → Likely fully-insured
- Check your Summary Plan Description (SPD):
- Contains ERISA statement and says "self-funded" or "self-insured" → ERISA exempt
- No ERISA statement, regulated by state → Subject to state mandates
- Call insurance customer service:
- Ask: "Is this plan fully-insured or self-funded? Is it subject to [State] insurance mandates?"
Using State Mandates in Your Appeal
Template Language for State Mandate Appeals
For California Residents:
"I am appealing the denial of [Wegovy/Zepbound/Ozempic/Mounjaro] for obesity treatment. Under California Health and Safety Code Section 1367.008 and Insurance Code Section 10112.28, my fully-insured health plan is required to cover FDA-approved obesity treatments for individuals with BMI ≥30 or BMI ≥27 with weight-related comorbidity.
I qualify with BMI [XX.X] and [hypertension/diabetes/dyslipidemia/sleep apnea]. The law prohibits requiring more than one prior authorization for obesity medications. This denial violates California law.
I am prepared to file a complaint with the California Department of Managed Health Care (DMHC) if this medically necessary treatment continues to be denied unlawfully. Please reverse this denial within [30 days/72 hours for urgent]."
For Illinois Residents:
"Under Illinois Public Act 103-0595 (effective January 1, 2024), my state-regulated health insurance plan is prohibited from imposing step therapy requirements for FDA-approved anti-obesity medications. [Drug name] is FDA-approved for obesity treatment, and I meet medical criteria with BMI [XX.X] and [comorbidity].
Requiring me to fail [metformin/other drugs] before accessing FDA-approved obesity medication violates Illinois law. I request immediate reversal of this denial and approval for [drug name] consistent with state requirements."
For New York/Massachusetts Residents (Diabetes):
"Under [New York Insurance Law Section 3216 / Massachusetts General Laws Chapter 176O], my insurance is required to provide comprehensive diabetes medication coverage. My Type 2 Diabetes (A1C [X.X]%, diagnosed [year]) requires GLP-1 therapy after failing [prior medications].
Denying medically necessary diabetes medication violates state law. My physician has determined this treatment is clinically appropriate based on [complications, prior failures, urgency]. Please approve this appeal consistent with state diabetes coverage requirements."
State Insurance Commissioner Complaints
When to File Commissioner Complaint
File if:
- You're in a state with GLP-1/obesity/diabetes mandate
- Your plan is fully-insured (subject to state law)
- Insurance denied despite state law requirements
- Internal appeal was denied or ignored
What Happens:
- Commissioner's office investigates potential law violation
- Insurance must respond to regulatory inquiry
- Often leads to reversal to avoid regulatory action
- Creates legal record if you need external review or legal action
How to File:
- Contact your state insurance department (phone numbers listed above)
- File online complaint or mail written complaint
- Include: Insurance ID, denial letter, state law citation, medical necessity letter
- Reference your internal appeal and denial
Timeline: Commissioner reviews typically take 30-60 days, but insurance often reverses denials quickly once complaint is filed to avoid regulatory scrutiny.
Federal Law: ACA Preventive Services
Obesity Screening & Counseling (Applies in ALL States)
ACA Requirement: All non-grandfathered health plans must cover obesity screening and intensive behavioral counseling for BMI ≥30 with no cost-sharing.
What This Covers:
- BMI calculation and obesity screening
- Intensive behavioral counseling (diet, exercise, lifestyle modification)
- NO copay, NO deductible for these services
What This Does NOT Cover:
- Obesity medications (Wegovy, Zepbound, etc.)
- Weight loss surgery
- Commercial weight loss programs
How to Use: If insurance requires documented "weight loss program" before approving GLP-1 drugs, use free ACA preventive counseling to meet this requirement. Then cite completion in appeal: "I completed 6 months intensive behavioral counseling (ACA preventive service) with weight loss of only [X lbs / X%], demonstrating need for pharmacotherapy."
Bottom Line: State Mandate Strategy
Strategic Recommendations by State
California, Illinois Residents (Strong Obesity Mandates):
- ALWAYS cite state law in appeal (first paragraph)
- Mention Insurance Commissioner complaint if denied
- Appeals that quote the state mandate statute by name and section perform meaningfully better than those that don't
NY, MA, CT, MD Residents (Diabetes Mandates):
- Cite diabetes mandate for Ozempic/Mounjaro denials
- Emphasize complications, A1C >8% for stronger argument
- Less effective for weight loss-only indication (Wegovy/Zepbound)
All Other States (No Mandate):
- Focus on medical necessity, prior failures, clinical evidence
- Consider prediabetes diagnosis if BMI qualifies + A1C 5.7-6.4%
- Stronger appeals: Doctor letter + peer-to-peer + urgency
Self-Funded Plan Holders (All States):
- State mandates do NOT apply to you (ERISA exemption)
- Appeal based on: Medical necessity, plan language, employer benefit design
- Consider external ERISA review if denied
Next Steps
- Check if your state has GLP-1/obesity/diabetes mandate (see above)
- Verify your plan type (fully-insured vs self-funded)
- If mandate applies: Include state law citation in appeal
- If no mandate: Focus on medical necessity strategies
Get Templates:
Related Articles
Ozempic vs Wegovy vs Mounjaro: Insurance Coverage Comparison
Compare insurance coverage for Ozempic, Wegovy, Mounjaro, and Zepbound with appeal strategies.
How to Get a Step Therapy Override for GLP-1 Medications
Strategies to bypass step therapy for Ozempic, Wegovy, Mounjaro, and Zepbound.
Ozempic Prior Authorization Denied? Here's What to Do
Learn the exact steps to appeal an Ozempic prior authorization denial with clinical evidence strategies.
Medical Necessity Laws by State: Know Your Rights
State-by-state guide to medical necessity laws, external review rights, and patient protections.